Potential side effects include anaphylaxis and infusion-related reactions such as rash and diarrhea. It was also shown to stand up against variants first reported in the U.K., South Africa, Brazil, California, New York and India. Gilead's shares rose 1.3% to $62.30, while Merck was up nearly 2% at $76.08. Reporting By Mrinalika Roy in Bengaluru; Editing by Shounak DasguptaOur Standards: The Thomson Reuters Trust Principles. Sotrovimab is a monoclonal antibody specifically directed against the spike protein of SARS-CoV-2 that is designed to block the virus attachment and entry into human cells.
More than 5 countries have patented an anti-inflammatory drug.
( z0 patent :ARG0 ( z1 country :quant ( z2 more-than :op 5 ) ) :ARG1 ( z3 drug :ARG0-of ( z4 counter :ARG1 ( z5 inflame ) ) ) )
(z0 / patent-01
    :ARG0 (z1 / country
              :quant (z2 / more-than
                         :op1 5))
    :ARG1 (z3 / drug
              :ARG0-of (z4 / counter-01
                           :ARG1 (z5 / inflame-01))))
More than 5 countries have patented an anti - inflammatory drug .
z2 :op1 0
z1 :quant z2
z0 :ARG0 z1
z4 :ARG1 z5
z3 :ARG0-of z4
z0 :ARG1 z3